Spatial access to sterile syringes and the odds of injecting with an unsterile syringe among injectors: A longitudinal multilevel study

Journal of Urban Health

Volumn 89, Issue 4, 2012, Pages 678-696

  Cooper, Hannah ^a   Des Jarlais, Don ^b   Ross, Zev ^c   Tempalski, Barbara ^e   Bossak, Brian H ^d   Friedman, Samuel R ^e  

^a EMORY UNIVERSITY   (United States)

^b BETH ISRAEL MEDICAL CENTER   (United States)

^c ZEVROSS SPATIAL ANALYSIS   (United States)

^d GEORGIA SOUTHERN UNIVERSITY   (United States)

^e NATIONAL DEVELOPMENT AND RESEARCH INSTITUTES   (United States)

Author keywords

Drug related law enforcement; Geospatial analyses; Harm reduction; HIV; Injection drug use; Syringe exchange programs

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CROSS-SECTIONAL STUDY; DRUG ABUSE; FEMALE; HEALTH CARE DELIVERY; HUMAN; LEGAL ASPECT; LONGITUDINAL STUDY; MALE; MULTILEVEL ANALYSIS; PREVENTIVE HEALTH SERVICE; RISK FACTOR; STATISTICS; SUBSTANCE ABUSE; SYRINGE; UNITED STATES;

ADOLESCENT; ADULT; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH SERVICES ACCESSIBILITY; HUMANS; LONGITUDINAL STUDIES; MALE; MULTILEVEL ANALYSIS; NEEDLE SHARING; NEEDLE-EXCHANGE PROGRAMS; NEW YORK CITY; RISK FACTORS; SUBSTANCE ABUSE, INTRAVENOUS; SYRINGES; YOUNG ADULT;

EID: 84865140844     PISSN: 10993460     EISSN: 14682869     Source Type: Journal    
DOI: 10.1007/s11524-012-9673-y     Document Type: Article

References (84)

1. US Congress. Consolidated Appropriations Act of 2010, PL111-117. In: US Congress, ed2009.
2. Tempalski B. Placing the dynamics of syringe exchange programs in the United States. Health and Place. 2007; 13(2): 417-431. (Pubitemid 46136068)
3. Tempalski B, Friedman R, Keem M, Cooper H, Friedman SR. NIMBY localism and national inequitable exclusion alliances: the case of syringe exchange programs in the United States. Geoforum. 2007; 38: 1250-1263. (Pubitemid 47500694)
4. Tempalski B, McQuie H. Drugscapes and the role of place and space in injection drug use-related HIV risk environments. International Journal of Drug Policy. 2009; 20(1): 4-13.
5. Bastos FI, Strathdee SA. Evaluating the effectiveness of syringe exchange programmes: current issues and future prospects. Social Science & Medicine. 2000; 51: 1771-1782.
6. Blankenship KM, Bray SJ, Merson MH. Structural interventions in public health. AIDS. 2000; 14(Suppl 1): S11-S21.
7. Des Jarlais DC. Structural interventions to reduce HIV transmission among injecting drug users. AIDS. 2000; 14(Suppl 1): S41-S46.
8. Rhodes T, Singer M, Bourgois P, Friedman SR, Strathdee SA. The social structural production of HIV risk among injecting drug users. Social Science & Medicine. 2005; 61 (5): 1026-1044. (Pubitemid 40805548)
9. Sumartojo E. Structural factors in HIV prevention: concepts, examples, and implications for research. AIDS. 2000; 14(suppl 1): S2-S10.
10. Cooper HL, Bossak BH, Tempalski B, Des Jarlais DC, Friedman SR. Geographic approaches to quantifying the risk environment: drug-related law enforcement and access to syringe exchange programmes. International Journal of Drug Policy. 2008; 20: 217-226.
11. Blankenship KM, Friedman SR, Dworkin S, Mantell J. Structural interventions: concepts, challenges, and opportunities for research. Journal of Urban Health. 2006; 83(1): 59-72. (Pubitemid 44337043)
12. Des Jarlais DC, Marmor M, Paone D, et al. HIV incidence among injecting drug users in New York City syringe-exchange programmes. Lancet. 1996; 348(9033): 987-991. (Pubitemid 26340754)
13. General Accounting Office. Needle exchange programs: research suggests promise as an AIDS prevention strategy. Washington, DC: Government Printing Office; 1993.
14. Gibson DR, Brand R, Anderson K, Kahn JG, Perales D, Guydish J. Two- to sixfold decreased odds of HIV risk behavior associated with use of syringe exchange. JAIDS. 2002; 31: 237-242. (Pubitemid 35190579)
15. Gibson DR, Flynn NM, Perales D. Effectiveness of syringe exchange programs in reducing HIV risk behavior and HIV seroconversion among injecting drug users. AIDS. 2001; 15: 1329-1341. (Pubitemid 32662285)
16. Ksobiech K. A meta-analysis of needle sharing, lending, and borrowing behaviors of needle exchange program attenders. AIDS Educ Prev. 2003; 15(3): 257-268. (Pubitemid 36791290)
17. Normand J, Vlahov D, Moses L. Preventing HIV transmission: the role of sterile needles and bleach. Washington, DC: National Academy Press; 1995.
18. World Health Organization. Effectiveness of sterile needle and syringe programming in reducing HIV/AIDS among injecting drug users. Geneva: World Health Organization; 2004.
19. Huo D, Bailey SL, Hershow RC, Ouellet L. Drug use and HIV risk practices of secondary and primary needle exchange users. AIDS Educ Prev. 2005; 17(2): 170-184. (Pubitemid 40604912)
20. Tyndall M, Bruneau J, Brogly S, Spittal P, O'Shaughnessy MV, Schechter M. Satellite needle distribution among injection drug users: policy and practice in two Canadian cities. JAIDS. 2002; 31: 98-105.
21. Valente T, Foreman R, Junge B, Vlahov D. Needle-exchange participation, effectiveness, and policy: syringe relay, gender, and the paradox of public health. Journal of Urban Health. 2001; 78(2): 340-349. (Pubitemid 32545536)
22. Valente T, Foreman R, Junge B, Vlahov D. Satellite exchange in the Baltimore needle exchange program. Public Health Reports. 1998; 113(Supplement 1): 90-96. (Pubitemid 29330150)
23. Lorvick J, Bluthenthal RN, Scott A, et al. Secondary syringe exchange among users of 23 California syringe exchange programs. Substance Use & Misuse. 2006; 41: 856-882.
24. Rockwell R, Des Jarlais DC, Friedman SR, Perlis TE, Paone D. Geographic proximity, policy and utilization of syringe exchange programmes. AIDS Care. 1999; 11(4): 437-442. (Pubitemid 29349206)
25. Cooper HL, Des Jarlais C, Ross Z, Tempalski B, Bossak B, Friedman S. Spatial access to syringe exchange programs and pharmacies selling over-the-counter syringes predicts drug injectors' use of sterile syringes. American Journal of Public Health. 2011; 101: 1118-1125.
26. Williams C, Metzger D. Race and distance effects on regular syringe exchange program use and injection risks: a geobehavioral analysis. Am J Public Health. 2010; 100(6): 1068-1074.
27. Friedman SR, Curtis R, Neaigus A, Jose B, Des Jarlais DC. Social networks, drug injectors' lives, and HIV/AIDS. New York: Kluwer; 1999.
28. Rhodes T. The 'risk environment': a framework for understanding and reducing drug-related harm. International Journal of Drug Policy. 2002; 13(2): 85-94. (Pubitemid 34607323)
29. Rhodes T, Mikhailova L, Sarang A, et al. Situational factors influencing drug injecting, risk reduction and syringe exchange in Togliatti City, Russian Federation: a qualitative study of micro risk environment. Social Science & Medicine. 2003; 57(1): 39-54. (Pubitemid 36566517)
30. Rhodes T. Risk environments and drug harms: a social science for harm reduction approach. International Journal of Drug Policy. 2009; 20: 193-201.
31. Cooper H, Moore L, Gruskin S, Krieger N. The impact of a police drug crackdown on drug injectors' ability to practice harm reduction: a qualitative study. Social Science & Medicine. 2005; 61(3): 673-684. (Pubitemid 40724611)
32. Grund JP, Heckathorn D, Anthony D. In Eastern Connecticut, IDUs purchase syringes from pharmacies but don't carry syringes. JAIDS. 1995; 10: 105.
33. Kerr T, Small W, Wood E. The public health and social impacts of drug market enforcement: a review of the evidence. International Journal of Drug Policy. 2005; 16: 210-220. (Pubitemid 41558178)
34. Koester S. Copping, running, and paraphernalia laws: contextual variables and needle risk behavior among injection drugs users in Denver. Hum Organ. 1994; 53(3): 287-295.
35. Maher L, Dixon D. Policing and public health: law enforcement and harm reduction in a street-level drug market. Br J Criminol. 1999; 39(4): 488-512.
36. Wood E, Kerr T, Small W, Jones J, Schechter M, Tyndall M. The impact of police presence on access to needle exchange programs. JAIDS. 2003; 34(1): 116-118. (Pubitemid 37100123)
37. Bluthenthal RN, Kral A, Erringer E, Edlin BR. Drug paraphernalia laws and injection-related infectious disease risk among drug injectors. Journal of Drug Issues. 1999; 29(1): 1-16. (Pubitemid 29202658)
38. Bluthenthal RN, Kral AH, Lorvick J, Watters JK. Impact of law enforcement on syringe exchange programs: a look at Oakland and San Francisco. Medical Anthropology. 1997; 18: 61-83. (Pubitemid 127822119)
39. Bluthenthal RN, Lorvick J, Kral AH, Erringer EA, Kahn JG. Collateral damage in the war on drugs: injection drug use. International Journal of Drug Policy. 1999; 10: 25-38. (Pubitemid 29251553)
40. Friedman SR, Cooper HL, Tempalski B, et al. Relationships of deterrence and law enforcement to drug-related harms among drug injectors in US metropolitan areas. AIDS. 2006; 20(1): 93-99. (Pubitemid 41818119)
41. Davis CS, Burris S, Kraut-Becher J, Lynch KG, Metzger D. Effects of an intensive street-level police intervention on syringe exchange program use in Philadelphia, PA. Am J Public Health. 2005; 95(2): 2333-2236.
42. Pouget ER, Deren S, Fuller CM, et al. Receptive syringe sharing among injection drug users in Harlem and the Bronx during the New York State Expanded Syringe Access Demonstration Program. J Acquir Immune Defic Syndr. 2005; 39(4): 471-477. (Pubitemid 41003795)
43. Fuller CM, Galea S, Caceres W, Blaney S, Sisco S, Vlahov D. Multilevel community-based intervention to increase access to sterile syringes among injection drug users through pharmacy sales in New York City. Am J Public Health. 2007; 97(1): 117-124. (Pubitemid 46067693)
44. The New York State AIDS Advisory Council. Report on Syringe Access in New York State. New York City: The New York State AIDS Advisory Council;2005.
45. Cooper HL, Wypij D, Krieger N. Police drug crackdowns and hospitalization rates for illicit-injection-related infections in New York City. International Journal of Drug Policy. 2005; 16: 150-160. (Pubitemid 40800202)
46. New York State Department of Health AIDS Institute. Expanded Syringe Access Program: Overview of the Law and Regulations. 2008; http://www.nyhealth. gov/diseases/aids/harm-reduction/needles-syringes/esap/overview.htm. Accessed January 7 2009.
47. Des Jarlais DC, Perlis T, Arasteh K, et al. "Informed altruism" and "Partner restriction" in the reduction of HIV infection in injecting drug users entering detoxification treatment in New York City, 1990-2001. JAIDS. 2004; 35(2): 158-166. (Pubitemid 38133740)
48. United Hospital Fund. UHF Health Atlas. New York City: United Hospital Fund;2005.
49. New York City Department of Health and Mental Hygiene. City Wide Community Health Profile. New York City: NYCDOH;2001.
50. New York City Department of Health and Mental Hygiene. New York City Community Health Profiles. 2006; http://www.nyc.gov/html/doh/html/data/data. shtml.
51. de Smith MJ, Goodchild MF, Longley PA. Geospatial analysis: a comprehensive guide to principles, techniques and software tools. Leicester, UK: Matador, an imprint of Troubador Publishing Ltd, on behalf of The Winchelsea Press; 2007.
52. Bluthenthal R, Do D, Finch B, Martinez A, Edlin B, Kral A. Community characteristics associated with HIV risk among injection drug users in the San Francisco Bay area: a multilevel analysis. Journal of Urban Health. 2007; 84(5): 653-666. (Pubitemid 47366980)
53. Centers for Disease Control and Prevention, Health Resources & Services Administration, National Institute on Drug Abuse of the National Institutes of Health, Administration tCfSATotSAaMHS. HIV prevention bulletin: Medical advice for persons who injectillicit drugs. 1997; http://www.cdcnpin. org/Reports/MedAdv.pdf.
54. Villano SA, Vlahov D, Nelson K, Lyles CM, Cohn S, Thomas DL. Incidence and risk factors for hepatitis C among injection drug users in Baltimore, Maryland. J Clin Microbiol. 1997; 35: 3274-3277. (Pubitemid 27505758)
55. Murphy EL, DeVita D, Liu H, et al. Risk factors for skin and soft tissue abscess among injection drug users: a case-control study. Clinical Infectious Disease. 2001; 33(1): 35-40. (Pubitemid 32554500)
56. Vlahov D, Sullivan M, Astemborski J, Nelson K. Bacterial infections and skin cleaning prior to injecting among intravenous drug users. Public Health Reports. 1992; 5: 595-598.
57. Des Jarlais C, Perlis T, Friedman SR, et al. Behavioral risk reduction in a declining HIV epidemic: injection drug users in New York City, 1990-1997. Am J Public Health. 2000; 90(7): 1112-1116. (Pubitemid 30445366)
58. Friedman SR, Ompad DC, Maslow C, et al. HIV prevalence, risk behaviors, and high-risk sexual and injection networks among young women injectors who have sex with women. Am J Public Health. 2003; 93(6): 902-906. (Pubitemid 38480217)
59. Marshall BDL, Wood E, Li K, Kerr T. Elevated syringe borrowing among men who have sex with men: a prospective study. J Acquir Immune Defic Syndr. 2007; 46(2): 248-252. (Pubitemid 47482623)
60. Des Jarlais DC, Braine N, Friedmann P. Unstable housing as a factor for increased injection risk behavior at US syringe exchange programs. Aids Behav. 2007; 11(6 Suppl): 78-84.
61. Montgomery SB, Hyde J, De Rosa CJ, et al. Gender differences in HIV risk behaviors among young injectors and their social network members. Am J Drug Alcohol Abuse. 2002; 28(3): 453-475. (Pubitemid 34913032)
62. Salazar LF, Crosby RA, Holtgrave DR, et al. Homelessness and HIV-associated risk behavior among African American men who inject drugs and reside in the urban south of the United States. AIDS Behav. 2007; 11(6 Suppl): 70-77.
63. Kottiri BJ, Friedman SR, Neaigus A, Curtis R, Des Jarlais DC. Risk networks and racial/ethnic differences in the prevalence of HIV infection among injection drug users. J Acquir Immune Defic Syndr. 2002; 30(1): 95-104. (Pubitemid 34506693)
64. Hartwig F, Dearing B. Exploratory data analysis. Newbury Park: Sage Publications; 1979.
65. Singer J, Willett J. Applied longitudinal data analysis: modeling change and event occurrence. New York City: Oxford University Press; 2003.
66. Raudenbush S, Bryk A. Hierarchical linear models: applications and data analysis methods. London: Sage; 2002.
67. McClelland GH, Judd CM. Statistical difficulties of detecting interactions and moderator effects. Psychol Bull. 1993; 114(2): 376-390.
68. Busemeyer JR, Jones LE. Analysis of multiplicative combination rules when the causal variables are measured with error. Psychol Bull. 1983; 93(4): 549-562.
69. Shields N, Nadasen K, Pierce L. The effects of community violence on children in Cape Town, South Africa. Child Abuse and Neglect. 2008; 32: 589-601. (Pubitemid 351758955)
70. Chae DH, Lincoln KD, Adler N, Syme SL. Do experiences of racial discrimination predict cardiovascular disease among African American men? The moderating role of internalized negative racial group attitudes. Social Science & Medicine. 2010; 71: 1182-1188.
71. Cooper ML. Toward a person situation model of sexual risk-taking behaviors: illuminating the conditional effects of traits across sexual situations and relationship contexts. J Personal Soc Psychol. 2010; 98(2): 319-341.
72. Wei M, Ku T-Y, Russell D, Liao KY-H, Mallinckrodt B. Moderating effects of three coping strategies and self-esteem on perceived discrimination and depressive symptoms: a minority stress model for asian international students. J Couns Psychol. 2008; 55(4): 451-462.
73. Chae DH, Takeuchi D, Barbeau EM, et al. Alcohol disorders among Asian Americans: associations with unfair treatment, racial/ethnic discrimination, and ethnic identification (the national Latino and Asian Americans study, 2002-2003). Journal of Epidemiology and Community Health. 2008; 62: 973-979.
74. Basagañaa X, Spiegelman D. Power and sample size calculations for longitudinal studies comparing rates of change with a time-varying exposure. Statistics in Medicine. 2009; 29: 181-192.
75. Des Jarlais DC, Perlis T, Arasteh K, et al. HIV incidence among injection drug users in New York City, 1990 to 2002: use of serologic test algorithm to assess expansion of HIV prevention services. Am J Public Health. 2005; 95(8): 1439-1444. (Pubitemid 41060542)
76. Marx MA, Crape B, Brookmeyer RS, et al. Trends in crime and the introduction of a needle exchange program. Am J Public Health. 2000; 90(12): 1933-1936.
77. Doherty MC, Junge B, Rathouz P, Garfein RS, Riley E, Vlahov D. The effect of a needle exchange program on numbers of discarded needles: a 2-year follow-up. Am J Public Health. 2000; 90: 936-939. (Pubitemid 30366979)
78. Kral AH, Anderson K, Flynn NM, Bluthenthal RN. Injection risk behaviors among clients of syringe exchange programs with different syringe dispensation policies. JAIDS. 2004; 37(2): 1307-1312. (Pubitemid 39281513)
79. Bluthenthal R, Ridgeway G, Schell T, Anderson R, Flynn N, Kral A. Examination of the association between syringe exchange program (SEP) dispensation policy and SEP client-level syringe coverage among injection drug users. Addiction. 2007; 102(4): 638-646. (Pubitemid 46398835)
80. Bluthenthal RN, Malik MR, Grau L, Singer M, Marshall P, Heimer R. Sterile syringe access conditions and variations in HIV risk among drug injectors in three cities. Addiction. 2004; 99: 1136-1146. (Pubitemid 39215275)
81. Bluthenthal RN, Anderson R, Flynn NM, Kral AH. Higher syringe coverage is associated with lower odds of HIV risk and does not increase unsafe syringe disposal among syringe exchange program clients. Drug and Alcohol Dependence. 2007; 89: 214-222. (Pubitemid 46759576)
82. Wood E, Spittal P, Small W, et al. Displacement of Canada's largest public illicit drug market in response to a police crackdown. CMAJ Canadian Medical Association Journal. 2004; 170(10): 1551-1556. (Pubitemid 38686186)
83. Aitken C, Moore D, Higgs P, Kelsall J, Kerger M. The impact of a police crackdown on a street drug scene: evidence from the street. International Journal of Drug Policy. 2002; 13: 193-202.
84. Bourgois P, Lettiere M, Quesada J. Social misery and the sanctions of substance abuse: confronting HIV risk among homeless heroin addictis in San Francisco. Soc Probl. 1997; 44(2): 155-173.